Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May;86(5):529-533.
doi: 10.1016/j.jinf.2023.01.019. Epub 2023 Jan 21.

Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients

Sonsoles Salto-Alejandre  1 , Marta Carretero-Ledesma  1 , Pedro Camacho-Martínez  1 , Judith Berastegui-Cabrera  1 , Carmen Infante  1 , Regino Rodríguez-Álvarez  2 , Jorge Alba  3 , Patricia Pérez-Palacios  4 , Emilio García-Díaz  5 , Cristina Roca  1 , Julia Praena  1 , María José Blanco-Vidal  2 , Sonia Santibáñez  3 , Rocío Valverde-Ortiz  6 , Javier Nieto-Arana  2 , Concepción García-García  3 , David Gutiérrez-Campos  4 , Natalia Maldonado  7 , Gabriel Bernal  8 , Miguel Ángel Gómez-Bravo  9 , José Manuel Sobrino  10 , Manuela Aguilar-Guisado  11 , Rocío Álvarez-Marín  11 , Josune Goikoetxea-Aguirre  2 , José Antonio Oteo  3 , Zaira R Palacios-Baena  7 , Álvaro Pascual  12 , José Antonio Lepe  13 , Jesús Rodríguez-Baño  14 , José Miguel Cisneros  15 , Jerónimo Pachón  16 , Javier Sánchez-Céspedes  17 , Elisa Cordero  15 ; COVIDSOT Working Team
Affiliations
Comment

Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients

Sonsoles Salto-Alejandre et al. J Infect. 2023 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have declared that no competing interests exist.

Figures

Fig 1
Fig. 1
SOT recipients (n = 47) comparison with no SOT patients (n=408) regarding (A) undetectable IFN-α and IFN-γ serum levels, RNAemia, and mortality, by days from symptoms onset at hospital admission, and (B) Survival Kaplan Meier analysis of patients with and without undetectable IFN-γ serum levels and RNAemia detection.
Fig 1
Fig. 1
SOT recipients (n = 47) comparison with no SOT patients (n=408) regarding (A) undetectable IFN-α and IFN-γ serum levels, RNAemia, and mortality, by days from symptoms onset at hospital admission, and (B) Survival Kaplan Meier analysis of patients with and without undetectable IFN-γ serum levels and RNAemia detection.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int (accessed 13 January 2023).
    1. Chen D., Pan Y., Wang Y., Chen X., Zhang J., Zhang Y., et al. Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies. J Infect. 2022;S0163-4453(22):00673–00679. doi: 10.1016/j.jinf.2022.11.012. Epub ahead of print. - DOI - PMC - PubMed
    1. Marra A.R., Kobayashi T., Suzuki H., Alsuhaibani M., Tofaneto B.M., Bariani L.M., et al. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis. J Infect. 2022;84(3):297–310. doi: 10.1016/j.jinf.2021.12.035. - DOI - PMC - PubMed
    1. Onodi F., Bonnet-Madin L., Meertens L., Karpf L., Poirot J., Zhang S.Y., et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. J Exp Med. 2021;218(4) doi: 10.1084/jem.20201387. - DOI - PMC - PubMed
    1. Severa M., Diotti R.A., Etna M.P., Rizzo F., Fiore S., Ricci D., et al. Differential plasmacytoid dendritic cell phenotype and type I interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog. 2021;17(9) doi: 10.1371/journal.ppat.1009878. - DOI - PMC - PubMed